MyAverix Finance
US · Healthcare
Astellas Pharma Inc (ALPMY)
Drug Manufacturers - General
Astellas Pharma Inc (ALPMY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALPMY
Astellas Pharma Inc (ALPMY) — FAQ
What is ALPMY's P/E ratio?
The price-to-earnings (P/E) ratio for Astellas Pharma Inc (ALPMY) is 18.00 (data as of 2026-03-23).
Does Astellas Pharma Inc pay a dividend?
Dividend yield is not available in the current snapshot for Astellas Pharma Inc (ALPMY). Check the MyAverix Finance app for the latest dividend data.
What sector is Astellas Pharma Inc in?
Astellas Pharma Inc (ALPMY) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is ALPMY listed on?
ALPMY is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.